Key Points
- Philip Morris International has established a global Generative AI Factory at its Tabaqueira facility in Portugal.
- The center will develop and deploy AI solutions supporting PMI’s global operations.
- The initiative is led by PMI Head of AI Tomi Virkki and may involve around 100 specialists depending on project needs.
- Applications include industrial process optimization, data analytics, operational automation and AI-powered tools.
- PMI’s technology hub in Portugal has more than 250 specialists in AI, software engineering, cybersecurity and data management.
2Firsts
August 27, 2026
According to information released by Portugal’s Trade & Investment Agency (AICEP) in July 2026, Philip Morris International (PMI) has selected its Portuguese subsidiary Tabaqueira to host the company’s global Generative Artificial Intelligence Factory (GenAI Factory). Located at Tabaqueira’s Albarraque facility, the center will support PMI’s global operations through the development and deployment of AI solutions.
The initiative forms part of PMI’s broader digital transformation strategy and strengthens Tabaqueira’s role within the company’s global technology and innovation network.
PMI Builds Global Generative AI Capability Center
PMI said the GenAI Factory will serve as a global artificial intelligence capability center responsible for developing and implementing generative AI solutions across different business areas.
The center is led by Tomi Virkki, PMI’s Head of AI, with engineering and technology specialists supporting AI development, application deployment and solution implementation.
Depending on project requirements, the initiative may involve around 100 AI specialists. The operating model combines PMI’s internal strategic capabilities with technical support from external technology partners.
AI Applications Target Manufacturing and Operations
PMI said tools and applications developed by the GenAI Factory will support multiple areas across the company.
Key application areas include:
● industrial process optimization;
● data analytics;
● operational automation;
● development of AI-based applications.
For a global tobacco company transitioning toward smoke-free products, AI capabilities are becoming increasingly important for improving manufacturing processes, operational efficiency and global business management.
Portugal Strengthens Role in PMI Technology Network
The launch of the GenAI Factory in Portugal is part of PMI’s broader expansion of technology and shared service capabilities in the country.
PMI currently operates two global service hubs in Portugal:
● PMI Tech Hub Portugal;
● Finance Hub.
PMI Tech Hub Portugal is the company’s second-largest technology hub globally, with more than 250 specialists in artificial intelligence, software engineering, cybersecurity and data management.
The Finance Hub supports operations across 180 markets.
Around 26% of Tabaqueira employees currently perform global roles, highlighting Portugal’s growing strategic importance within PMI’s global organization.
Tobacco Companies Accelerate Digital Transformation
Global tobacco companies have increasingly invested in artificial intelligence, automation and data analytics to improve manufacturing, supply chains and business operations.
PMI’s establishment of the GenAI Factory in Portugal reflects the broader trend of tobacco companies integrating AI capabilities into their global operating models.
For the tobacco and nicotine industries, AI adoption may expand into manufacturing optimization, supply chain management, market analysis and internal operational efficiency.
Follow 2Firsts for the latest global tobacco and nicotine industry developments, corporate strategies and market insights.
Cover Image Source: Portugal Global / AICEP
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
